Cacace Angela M 4

What Happened Angela M. Cacace, Chief Scientific Officer of Arvinas, sold 4,592 shares of Arvinas common stock on February 13, 2026 at $11.89 per share, generating proceeds of $54,599. The sale is reported as a disposition (code S) and was not a discretionary trade — it was executed automatically to satisfy tax withholding related to the vesting and settlement of 25% of RSUs granted on February 13, 2025.

Key Details

• Transaction date and price: February 13, 2026 — 4,592 shares @ $11.89 each.
• Total proceeds: $54,599.
• Reason/footnote: Sale was automatic to cover tax withholding for RSU vesting (Footnote F1); not a voluntary market-timing sale.
• Holdings note: Filing indicates the insider’s holdings include an aggregate of 1,576 shares previously purchased under the 2018 Employee Stock Purchase Plan (Footnote F2).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Timeliness: Form 4 filed on Feb 18, 2026 — within the SEC’s two-business-day filing window for this Feb 13 transaction (timely).

Context This was a routine, automatic sell-to-cover transaction tied to RSU vesting (tax withholding), which is common and does not necessarily indicate the insider’s view on the company’s prospects. Purchases typically provide stronger signals of insider conviction; this transaction appears administrative.